[Translated article] A Rare Case of Cutaneous Angiosarcoma Secondary to Chronic Lymphedema in a Patient on Hemodialysis

Carballido Vázquez, A. M; Delgado Mucientes, C. M; Martínez García, G; Manchado López, P.
Actas dermo-sifiliogr. (Ed. impr.) ; 115(1): t87-t87, jan. 2024. ilus
Artículo en Inglés | IBECS (España) | ID: ibc-229353

Documentos relacionados

  1. Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta-analysis.
  2. Real-World Effectiveness of Omalizumab in Chronic Urticaria: A Clinical Observational Study.
  3. Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.
  4. A localized salt-dependent aquagenic urticaria successfully treated with omalizumab.
  5. Plasma matrix metalloproteinase-9 level change with omalizumab treatment in chronic spontaneous urticaria.
  6. Adyuvant Use of Omalizumab in Desensitization to Chemotherapeutics: Beyond IgE-Mediated Reactions.
  7. Who are the potential patients for omalizumab for food allergy?
  8. Comment on ''how does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria?'': reply from author.
  9. Biomarkers predicting the controller dose of omalizumab in patients with chronic spontaneous urticaria.
  10. Comment on "The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticarial": reply from authors.